NDC 0002-8905 – Taltz

Ixekizumab 40 mg/.5mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC0002-8905

Product details

Brand name
Taltz
Generic name
Ixekizumab
Labeler
Eli Lilly and Company
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA125521
Marketed since
February 2, 2024
Listing expires
December 31, 2027
Pharmacologic class
Interleukin-17A Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Taltz →

Package NDC codes (1)

Package NDCDescriptionSince
0002-8905-111 SYRINGE in 1 CARTON (0002-8905-11) / .5 mL in 1 SYRINGE (0002-8905-01)Feb 2, 2024

Other Taltz products